Trigger finger causes a finger or thumb to catch or lock when a tendon has trouble gliding through its sheath [4]. The tendon problem is distinct from diabetic peripheral neuropathy, which affects nerves and sensation. Usual care can include splinting or a corticosteroid injection. If symptoms persist, a surgeon may consider releasing the A1 pulley to make room for the tendon to glide [4].
What happened after a steroid injection?
One health records study matched 5,863 GLP-1 users with 5,863 nonusers. All had type 2 diabetes and received an initial corticosteroid injection for trigger finger. At one year, 10.6% of users and 11.9% of nonusers had a release (RR 0.89, 95% CI 0.81 to 0.99). At two years, 14.2% and 15.7% had surgery, respectively (RR 0.90, 95% CI 0.83 to 0.98). The difference at six months was statistically inconclusive [1].
A second study of people with type 2 diabetes found fewer trigger finger diagnoses among GLP-1 users overall and more release procedures among users who already had trigger finger[2]. That group was defined by a trigger finger diagnosis. The first study followed patients specifically after a steroid injection, so the two results answer different questions.
What happened after surgery?
In a third records study, each matched group included 4,283 patients who had a release. At one year, patients with GLP-1 exposure had more recorded pain (21.6% vs. 16.9%), scarring (2.3% vs. 1.5%), wound complications (2.3% vs. 1.4%), and repeat releases (11.4% vs. 9.5%) [3]. Infection rates were statistically similar.
Researchers counted GLP-1 exposure during the year before or after surgery. Because some patients could have had complications before starting the drug, this matters when interpreting the evidence on wound healing with GLP-1 drugs. The second study used preoperative exposure and found similar rates of selected complications within 90 days, including surgical site infection, joint stiffness and wound separation[2].
If you take a GLP-1 drug and plan to have surgery, discuss how to manage it before the procedure with your surgical team. These trigger finger studies did not test whether pausing medication changes surgical outcomes.